Cargando…

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

BACKGROUND: Image-guided radiotherapy (IGRT) increases the accuracy of treatment delivery through daily target localisation. We report on toxicity symptoms experienced during radiotherapy treatment, with and without IGRT in prostate cancer patients treated radically. METHODS: Between 2006 and 2009,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gill, Suki, Thomas, Jessica, Fox, Chris, Kron, Tomas, Rolfo, Aldo, Leahy, Mary, Chander, Sarat, Williams, Scott, Tai, Keen Hun, Duchesne, Gillian M, Foroudi, Farshad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217047/ https://www.ncbi.nlm.nih.gov/pubmed/22035354 http://dx.doi.org/10.1186/1748-717X-6-145

Ejemplares similares

Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging
por: Gill, Suki, et al.
Publicado: (2014)

Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer
por: Mak, Daisy, et al.
Publicado: (2012)

Ten-year results of quality assurance in radiotherapy chart round
por: Taghavi Bayat, Bardia, et al.
Publicado: (2013)

Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned
por: Pham, Daniel, et al.
Publicado: (2013)

What benefit could be derived from on-line adaptive prostate radiotherapy using rectal diameter as a predictor of motion?
por: Oates, Richard, et al.
Publicado: (2015)

Geographical miss of the prostate during image‐guided radiotherapy with a 6‐mm posterior expansion margin
por: Oates, Richard, et al.
Publicado: (2016)

Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients
por: Ng, Sweet Ping, et al.
Publicado: (2017)

A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer
por: Foroudi, Farshad, et al.
Publicado: (2012)

A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer
por: Yeh, Janice, et al.
Publicado: (2021)

An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy
por: Siva, Shankar, et al.
Publicado: (2013)

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy
por: Hardcastle, Nicholas, et al.
Publicado: (2019)

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT
por: Jackson, Price, et al.
Publicado: (2014)

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial
por: Schofield, Penelope, et al.
Publicado: (2016)

Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer
por: Hardcastle, Nicholas, et al.
Publicado: (2021)

A case study evaluating deep inspiration breath‐hold and intensity‐modulated radiotherapy to minimise long‐term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma
por: Tomaszewski, Jonathan M., et al.
Publicado: (2017)

Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma
por: Reynolds, Hayley M., et al.
Publicado: (2018)

Use of magnetic resonance image‐guided radiotherapy for breast cancer: a scoping review
por: Berlangieri, Alexandra, et al.
Publicado: (2021)

Use of magnetic resonance imaging-guided radiotherapy for breast cancer: a scoping review protocol
por: Elliott, Sarah, et al.
Publicado: (2021)

First Australian experience of treating localised prostate cancer patients with CyberKnife stereotactic radiotherapy: early PSA response, acute toxicity and quality of life
por: Dixit, Ashutosh, et al.
Publicado: (2017)

Reduction of margins in external beam radiotherapy
por: Kron, Tomas
Publicado: (2008)

Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinoma
por: White, Rohen, et al.
Publicado: (2016)

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes
por: Wu, Raymond, et al.
Publicado: (2015)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Enhancing the efficacy of immunotherapy using radiotherapy
por: Keam, Synat, et al.
Publicado: (2020)

Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2021)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2023)

Single-fraction magnetic resonance guided stereotactic radiotherapy – A game changer?
por: Kron, Tomas, et al.
Publicado: (2020)

Comparison of four 3D conformal treatment techniques to optimise radiotherapy treatment for anal cancer
por: Cray, Alison, et al.
Publicado: (2014)

Genetics and genomics of radiotherapy toxicity: towards prediction
por: West, Catharine M, et al.
Publicado: (2011)

Reducing cardiac doses: a novel multi‐leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left‐sided breast cancer
por: Welsh, Briana, et al.
Publicado: (2016)

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
por: Sveistrup, Joen, et al.
Publicado: (2014)

Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy
por: Taylor, Michael L., et al.
Publicado: (2011)

Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre
por: Sia, Joseph, et al.
Publicado: (2011)

Comparison of conventional versus customised Eurosil-4 Pink bolus for radiotherapy of the chest wall
por: Gill, Ashlesha, et al.
Publicado: (2022)

Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
por: Gill, Suki, et al.
Publicado: (2022)

Impact through versatility: Patterns of in vivo dosimetry utilization with TLD across a large multi-site radiotherapy department
por: Lonski, Peta, et al.
Publicado: (2022)

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
por: Hardcastle, Nicholas, et al.
Publicado: (2023)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k31p0oeh7vhds6pkivq7dc4c62